Literature DB >> 16681340

Cervical smear participation and prevalence of sexually transmitted infections in women attending a community-controlled Indigenous health service in north Queensland.

K S Panaretto1, D Dallachy, V Manessis, S Larkins, S Tabrizi, J Upcroft, S Garland.   

Abstract

OBJECTIVE: To increase Pap smear participation and to assess the prevalence of sexually transmitted infection (STI) in urban Indigenous women in Townsville.
DESIGN: Convenience sample of women attending Townsville Aboriginal and Islanders Health Services (TAIHS) for health care participating in the Trichomonas vaginalis (TV) project, coordinated by an Aboriginal Health Worker (AHW) trained in women's health and cervical screening. PARTICIPANTS: 198 women, aged 20-69 years of age, attending TAIHS between March 2002 and 31 January 2004. MAIN OUTCOME MEASURES: Pap smear participation and prevalence of STIs.
RESULTS: Pap smear participation among eligible women at TAIHS increased from 20.9% pre TV project to 28.6% during the project and 35.6% in the 12 months post completion of the TV project (p<0.0001), an increase of 70.3%. Of 196 smears performed during the study, 20 (10.6%, 95% CI 6.2-15) were abnormal; abnormality was more common in non-Indigenous 8/50 (16.0%) than in Indigenous women 12/139 (8.6%), but did not reach significance (p=0.180). The prevalence of Chlamydia trachomatis was low, with no differences between the Indigenous and non-Indigenous groups, and highest in younger women: 6/44 (13.6%) in women less than 25 years; Trichomonas vaginalis was more common in the Indigenous group.
CONCLUSION: An AHW trained to perform and advocating for Pap smear participation has significantly increased the smear participation at TAIHS. The overall prevalence of STI was low.

Entities:  

Mesh:

Year:  2006        PMID: 16681340     DOI: 10.1111/j.1467-842x.2006.tb00112.x

Source DB:  PubMed          Journal:  Aust N Z J Public Health        ISSN: 1326-0200            Impact factor:   2.939


  6 in total

1.  Susceptibility in vitro of clinically metronidazole-resistant Trichomonas vaginalis to nitazoxanide, toyocamycin, and 2-fluoro-2'-deoxyadenosine.

Authors:  Janelle M Wright; Linda A Dunn; Zygmunt Kazimierczuk; Anita G Burgess; Kenia G Krauer; Peter Upcroft; Jacqueline A Upcroft
Journal:  Parasitol Res       Date:  2010-06-09       Impact factor: 2.289

2.  Service Level Factors Associated with Cervical Screening in Aboriginal and Torres Strait Islander Primary Health Care Centres in Australia.

Authors:  Abbey Diaz; Brenda Vo; Peter D Baade; Veronica Matthews; Barbara Nattabi; Jodie Bailie; Lisa J Whop; Ross Bailie; Gail Garvey
Journal:  Int J Environ Res Public Health       Date:  2019-09-27       Impact factor: 3.390

3.  Access to Aboriginal Community-Controlled Primary Health Organizations Can Explain Some of the Higher Pap Test Participation Among Aboriginal and Torres Strait Islander Women in North Queensland, Australia.

Authors:  Paramita Dasgupta; John R Condon; Lisa J Whop; Joanne F Aitken; Gail Garvey; Mark Wenitong; Peter D Baade
Journal:  Front Oncol       Date:  2021-07-28       Impact factor: 6.244

Review 4.  Appraising community driven health research with Aboriginal and Torres Strait Islander communities: a scoping review using the Aboriginal and Torres Strait Islander Quality Appraisal Tool.

Authors:  Brett Biles; Jessica Biles; Kate Friere; Linda Deravin; Jayne Lawrence; Aryati Yashadhana
Journal:  Health Promot Int       Date:  2022-10-01       Impact factor: 3.734

Review 5.  The prevalence of Chlamydia trachomatis infection in Australia: a systematic review and meta-analysis.

Authors:  Dyani Lewis; Danielle C Newton; Rebecca J Guy; Hammad Ali; Marcus Y Chen; Christopher K Fairley; Jane S Hocking
Journal:  BMC Infect Dis       Date:  2012-05-14       Impact factor: 3.090

6.  The first comprehensive report on Indigenous Australian women's inequalities in cervical screening: A retrospective registry cohort study in Queensland, Australia (2000-2011).

Authors:  Lisa J Whop; Gail Garvey; Peter Baade; Joan Cunningham; Kamalini Lokuge; Julia M L Brotherton; Patricia C Valery; Dianne L O'Connell; Karen Canfell; Abbey Diaz; David Roder; Dorota Gertig; Suzanne P Moore; John R Condon
Journal:  Cancer       Date:  2016-04-11       Impact factor: 6.860

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.